Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
Positive clinical results from Alcohol Use Disorder clinical trial may strengthen potential for eligibility for Breakthrough Therapy ...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), ...
100% conversion of all 4 new opportunities in New York State into 4 new direct county customers ...
Customer advances from sample testing to serial orders, reinforcing confidence in Maris-Tech’s technology by the global defense market ...
This article is about a real event. It is not satire, parody, or metaphor. In late April 2026, OpenAI publicly explained why ...
GAAP Earnings Per Share -- $0.66 per diluted share was reported. Non-GAAP Earnings Per Share -- $0.79 per diluted share was ...
Q2 2026 Guidance -- Revenue $205 million; gross margin ~43%; operating expenses ~$59 million; adjusted EBITDA ~$34 million; ...
SpaceX is reiterated as a buy, driven by an updated IPO timeline, higher valuation, and likely accelerated S&P 500 inclusion.
The U.S. Office of Space Commerce (“OSC”) has released a proposal for streamlining regulatory approval of novel commercial ...
This valuable study presents a comprehensive comparison of human and macaque monkey behavior across a range of visual perceptual phenomena. The use of a unified oddball visual search paradigm enables ...
This was revealed by FRU chief executive officer Koli Sewabu last Saturday following the Annual General Meeting (AGM) at ...